Timo Myöhänen

Professor Timo Myöhänen is a prominent academic at the University of Helsinki's Department of Pharmacology within the Faculty of Medicine Medicum. His work focuses on drug development targeting neurodegenerative diseases, particularly Parkinson's and tauopathies, through the study of prolyl oligopeptidase (POP) inhibitors and autophagy mechanisms. He holds a PhD in Pharmacy and has authored over 60 peer-reviewed publications.

• Affiliations: University of Helsinki, Department of Pharmacology, Faculty of Medicine Medicum
• Education: PhD in Pharmacy (2008), Docent in Pharmacology (2012)

Research interests include alpha-synuclein aggregation, tau pathology, and the role of prolyl oligopeptidase in neurodegeneration. Notable projects involve developing novel small-molecule ligands for disease-modifying therapies. He has supervised multiple doctoral theses and serves on editorial and review boards for journals like Science Translational Medicine and Autophagy.

Key achievements include the 2008 Farmasian tutkijakoulun väitöskirjapalkinto award and extensive grants funded by organizations like the Sigrid Jusélius Foundation and AddF. His work bridges basic pharmacology with clinical applications, emphasizing translational research in neurodegenerative therapies.